JPM

243.31

+0.43%↑

AXP

265.57

+0.87%↑

RY

117.1

+0.45%↑

MMC

214.96

-1.45%↓

TD

62.11

+0.32%↑

JPM

243.31

+0.43%↑

AXP

265.57

+0.87%↑

RY

117.1

+0.45%↑

MMC

214.96

-1.45%↓

TD

62.11

+0.32%↑

JPM

243.31

+0.43%↑

AXP

265.57

+0.87%↑

RY

117.1

+0.45%↑

MMC

214.96

-1.45%↓

TD

62.11

+0.32%↑

JPM

243.31

+0.43%↑

AXP

265.57

+0.87%↑

RY

117.1

+0.45%↑

MMC

214.96

-1.45%↓

TD

62.11

+0.32%↑

JPM

243.31

+0.43%↑

AXP

265.57

+0.87%↑

RY

117.1

+0.45%↑

MMC

214.96

-1.45%↓

TD

62.11

+0.32%↑

Search

KKR & Co LP

Avatud

SektorRahandus

113.36 1.72

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

111.62

Max

114.01

Põhinäitajad

By Trading Economics

Sissetulek

784M

1.4B

Müük

-1.5B

3.2B

P/E

Sektori keskmine

29.863

20.525

Aktsiakasum

1.32

Dividenditootlus

0.71

Kasumimarginaal

43.254

Töötajad

4,834

EBITDA

45M

2.5B

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+31.54% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

0.71%

4.36%

Järgmine tulemuste avaldamine

1. mai 2025

Järgmine aktsia dividendi kuupäev (ex-date)

12. mai 2025

Turustatistika

By TradingEconomics

Turukapital

-26B

95B

Eelmine avamishind

111.64

Eelmine sulgemishind

113.36

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bullish Evidence

KKR & Co LP Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

22. apr 2025, 06:50 UTC

Omandamised, ülevõtmised, äriostud

KKR Launches $1.2 Billion Takeover Bid For Swedish Life-Sciences Company Biotage

14. apr 2025, 11:46 UTC

Omandamised, ülevõtmised, äriostud

CME Group, S&P Group Agree to Sell OSTTRA to KKR in $3.1 Billion Deal

9. apr 2025, 10:24 UTC

Omandamised, ülevõtmised, äriostud

EQT to Sell Karo Healthcare to KKR

9. apr 2025, 07:09 UTC

Omandamised, ülevõtmised, äriostud

Assura Accepts $2 Billion Takeover Offer From KKR Consortium

9. apr 2025, 06:02 UTC

Omandamised, ülevõtmised, äriostud

KKR Nears $2.85 Billion Deal With EQT For E45 Maker Karo Healthcare, FT Reports, Citing Sources

7. apr 2025, 14:42 UTC

Omandamised, ülevõtmised, äriostud

Assura Agrees to Primary Health Properties Bid Deadline Extension

4. apr 2025, 10:15 UTC

Suurimad hinnamuutused turgudel
Omandamised, ülevõtmised, äriostud

Gerresheimer Shares Fall After Report That KKR Exited Consortium Seeking Bid

4. apr 2025, 09:39 UTC

Omandamised, ülevõtmised, äriostud

KKR Drops Out of Consortium Attempting Gerresheimer Takeover, Bloomberg Says, Citing Sources

3. apr 2025, 14:57 UTC

Omandamised, ülevõtmised, äriostud

Primary Health Proposes $1.95 Billion Bid for Assura -- Update

3. apr 2025, 07:17 UTC

Omandamised, ülevõtmised, äriostud

Primary Health Proposes $1.95 Billion Bid for Assura

22. apr 2025, 06:04 UTC

Omandamised, ülevõtmised, äriostud

KKR: Offer Price Represents 60% Premium to Thursday's Closing Price

22. apr 2025, 06:03 UTC

Omandamised, ülevõtmised, äriostud

KKR: Biotage Board Recommends Shareholders Accept Offer

22. apr 2025, 06:02 UTC

Omandamised, ülevõtmised, äriostud

KKR: Offer Values Biotage at SEK11.61B

22. apr 2025, 06:02 UTC

Omandamised, ülevõtmised, äriostud

KKR Makes SEK145 a Share Bid For Biotage

18. apr 2025, 00:00 UTC

Peamised uudised

Private Equity World Engulfed by Perfect Storm -- WSJ

14. apr 2025, 11:31 UTC

Peamised uudised
Omandamised, ülevõtmised, äriostud

CME Group, S&P Group Agree to Sell OSTTRA to KKR in $3.1B Deal

14. apr 2025, 11:02 UTC

Omandamised, ülevõtmised, äriostud

KKR: Making OSTTRA Investment Primarily Through North America Private-Equity Strategy >KKR

14. apr 2025, 11:01 UTC

Omandamised, ülevõtmised, äriostud

S&P Global, CME to Divide Sale Proceeds Evenly Pursuant to 50/50 Joint Venture >SPGI CME

14. apr 2025, 11:00 UTC

Omandamised, ülevõtmised, äriostud

S&P Global, CME Group to Sell OSTTRA to KKR for $3.1 Billion >SPGI CME KKR

14. apr 2025, 11:00 UTC

Omandamised, ülevõtmised, äriostud

S&P Global and CME Group to Sell OSTTRA to KKR for $3.1 Billion

11. apr 2025, 11:56 UTC

Omandamised, ülevõtmised, äriostud

KKR Now Owns 30% of Enilive

11. apr 2025, 11:55 UTC

Omandamised, ülevõtmised, äriostud

KKR Completes Acquisition of Additional Stake in Enilive

9. apr 2025, 09:51 UTC

Omandamised, ülevõtmised, äriostud

EQT to Sell Karo Healthcare to KKR for an Undisclosed Amount

9. apr 2025, 09:32 UTC

Omandamised, ülevõtmised, äriostud

EQT: Transaction Expected to Close in Coming Months

9. apr 2025, 09:31 UTC

Omandamised, ülevõtmised, äriostud

EQT to Sell Karo Healthcare to KKR

3. apr 2025, 08:17 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Primary Health Properties' Lower Bid for Assura Is a Calculated Risk -- Market Talk

28. märts 2025, 09:34 UTC

Omandamised, ülevõtmised, äriostud

Topcon: Tender Offer Expected to Start Around End-July >7732.TO

28. märts 2025, 09:33 UTC

Omandamised, ülevõtmised, äriostud

Topcon: CEO Takashi Eto Also Plans to Participate in Tender Offer, Make Reinvestment After Completion of Offer >7732.TO

28. märts 2025, 09:31 UTC

Omandamised, ülevõtmised, äriostud

Topcon: JICC Plans to Indirectly Hold Voting Rights in Topcon >7732.TO

28. märts 2025, 09:31 UTC

Omandamised, ülevõtmised, äriostud

Topcon: KKR Plans to Indirectly Hold Majority Interest in Topcon >7732.TO

Võrdlus sarnastega

Hinnamuutus

KKR & Co LP Prognoos

Hinnasiht

By TipRanks

31.54% tõus

12 kuu keskmine prognoos

Keskmine 140.5 USD  31.54%

Kõrge 194 USD

Madal 114 USD

Põhineb 12 Wall Streeti analüütiku instrumendi KKR & Co LP 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

12 ratings

11

Osta

1

Hoia

0

Müü

Tehniline skoor

By Trading Central

101.87 / N/AToetus ja vastupanu

Lühikene perspektiiv

Very Strong Bullish Evidence

Keskpikk perspektiiv

Bearish Evidence

Pikk perspektiiv

Weak Bearish Evidence

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest KKR & Co LP

KKR & Co. Inc. is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, turnaround, lower middle market, and middle market investments. The firm considers investments in all industries with a focus on software, security, semiconductors, consumer electronics, internet of things (iot), internet, information services, information technology infrastructure, financial technology, network and cyber security architecture, engineering and operations, content, technology and hardware, energy and infrastructure, real estate, services industry with a focus on business services, intelligence, industry-leading franchises and companies in natural resource, containers and packaging, agriculture, airports, ports, forestry, electric utilities, textiles, apparel and luxury goods, household durables, digital media, insurance, brokerage houses, non-durable goods distribution, supermarket retailing, grocery stores, food, beverage, and tobacco, hospitals, entertainment venues and production companies, publishing, printing services, capital goods, financial services, specialized finance, pipelines, and renewable energy. In energy and infrastructure, it focuses on the upstream oil and gas and equipment, minerals and royalties and services verticals. In real estate, the firm seeks to invest in private and public real estate securities including property-level equity, debt and special situations transactions and businesses with significant real estate holdings, and oil and natural gas properties. The firm also invests in asset services sector that encompasses a broad array of B2B, B2C and B2G services verticals including asset-based, transport, logistics, leisure/hospitality, resource and utility support, infra-like, mission-critical, and environmental services. Within Americas, the firm prefers to invest in consumer products; chemicals, metals and m